Condition Focus: Rheumatoid Arthritis, Osteoarthritis — Comprehensive Mechanistic Review

This 2023 review from Zhang and Qu in the International Journal of Molecular Sciences represents the most comprehensive published analysis of how photobiomodulation works in arthritic joint disease. Rather than examining a single pathway, the authors synthesized evidence across cellular, animal, and clinical studies to identify five distinct mechanisms through which PBM addresses joint inflammation and damage.

The five mechanisms identified are: angiogenesis (new blood vessel formation to support tissue repair), ATP stimulation (enhanced cellular energy production via mitochondrial activation), gene modulation (altered expression of inflammatory and repair-related genes), enzyme regulation (modulation of matrix metalloproteinases and other tissue-remodeling enzymes), and cytokine modulation (suppression of pro-inflammatory mediators and promotion of anti-inflammatory signals).

The review covers wavelengths from 632.8 nm to 1064 nm, power densities from 1.25 to 150 mW/cm², and energy densities from 0.18 to 214 J/cm² — providing the most complete parameter landscape available for arthritis-specific PBM. The authors examined both rheumatoid arthritis models (collagen-induced, adjuvant-induced) and osteoarthritis models (MIA, papain, surgical), demonstrating that PBM’s therapeutic effects are consistent across different forms of inflammatory and degenerative joint disease.

For gout specifically, the cytokine modulation and enzyme regulation mechanisms are directly relevant: gout flares are driven by the same IL-1β, TNF-α, and PGE₂ cascades that PBM suppresses in RA and OA models, and the matrix metalloproteinases involved in cartilage degradation play the same destructive role in chronic tophaceous gout.

G.O.A.T. for Gout Alignment:
The G.O.A.T.’s 660 nm + 850 nm wavelengths and 5 mW/cm² irradiance sit within the parameter ranges shown to be effective across the studies reviewed here. The five-mechanism framework confirms that the G.O.A.T. addresses joint disease through multiple simultaneous pathways — not a single intervention point — which is consistent with PBM’s advantage over single-target pharmaceutical approaches.

Link to original research here

Editor’s note: This review provides the mechanistic framework for understanding PBM in joint disease. For focused evidence on specific mechanisms covered here, the cytokine modulation pathway is demonstrated in a joint model by Tomazoni et al 2017, and the cartilage repair mechanisms are explored with human chondrocytes in Oliveira et al 2025. For the enzyme regulation pathway as it relates to fibrotic remodeling (relevant to tophi), see Jagdeo et al 2021. The synoviocyte-specific inflammation data is detailed in Ryu et al 2023.

Related Articles

• Effects of PBM on OA from In Vivo and In Vitro Studies – Narrative Review 2025
• Current Advances of PBM in Treating Knee Osteoarthritis – 2023
• PBM Ameliorates Inflammatory Parameters in Fibroblast-Like Synoviocytes – Ryu et al 2023
• Effects of PBM on Inflammatory Response in Experimental OA – Tomazoni et al 2017
• NIR PBM Stimulates Cartilage Matrix Synthesis in Human Chondrocytes – Oliveira et al 2025

Key Takeaways

• Five distinct PBM mechanisms identified for arthritis: angiogenesis, ATP stimulation, gene modulation, enzyme regulation, cytokine modulation
• Effective wavelength range spans 632.8–1064 nm with power densities from 1.25–150 mW/cm²
• Consistent efficacy across both RA and OA models — the inflammatory pathways are shared with gout
• Most comprehensive parameter table available for arthritis-specific PBM

Study Overview

Full Citation

Zhang R, Qu J. (2023). The mechanisms and efficacy of photobiomodulation therapy for arthritis: a comprehensive review. International Journal of Molecular Sciences, 24(19), 14293. View Publication